מקורות

03-9230851 

מחקרים מדעיים וקליניים הראו כי נוראייד מסייע
לחולי שבץ מוחי ואירוע מוחי בתהליך השיקום

* נוראייד מאושר ע"י משרד הבריאות
   כתוסף תזונה ללא התוויה רפואית
References*:
Pre-Clinical Studies:
  1. Heurteaux C, et al. Neuropharmacology 2010.
  2. Ming-Che Tsai et al. J NeuroimmunePharmacol October 2014.
  3. Quintard H, et al. Neuroscience 2014.
  4. Heurteaux C, et al. Cerebrovasc Dis 2013.
  5. MohaOuMaati H, et al. Neuropharmacology 2012.
  6. Quintard H, et al. Neuropharmacology 2011.
  7. Tsai et al - Therapeutic Efficacy of NeuroAiD (MLC 601) in Experimental TBI –J NeuroimmunePharmacol2014.
  8. Carine Gandin et al. Cerebrovasc Dis 2016;42:139–154
  9. Lorivel T et al. J Neurosci Res. 2015 Mar 29.
 
 
Ischemic Stroke and Cerebral Ischemia:
  1. Venketasubramanian et al. Cerebrovasc Dis 2015;39:309–318
  2. Venketasubramanian et al. Journal of Evidence-Based Medicine,2015.
  3. NarayanaswamyVenketasubramanian et al. Cerebrovasc Dis 2015;39:
  4. SiwapornChankrachang, MD. Et al. Journal of Stroke and Cerebrovascular Diseases 2015.
  5. Navarro J, et al. Int J Stroke 2014.
  6. ChenC, et al. Effects of MLC601 on Early Vascular Events in Patients After Stroke: The CHIMES study.Stroke 2013.
  7. Chen C, et al. Chinese Medicine Neuroaid Efficacy on Stroke Recovery : A Double-Blind, Placebo-Controlled,Randomized Study. Stroke 2013.
  8. Siddiqui FJ, et al. Cerebrovasc Dis 2013.
  9. Chen C, et al. Stroke 2009.
  10. Harandi AA, et al. Stroke Res Treat 2011.
  11. Shahripour RB, et al. Eur Intern Med 2011.
  12. Kong KH, et al. Cerebrovasc Dis 2009.
  13. Ghandehari K, et al. Neural Regen Res 2011.
  14. Navarro JC, et al. Rehabil Res Pract 2012.
  15. Siow C, EurNeurol 2008.
  16. Zaki N Hasan et al. IRAQI J MED SCI, 2012; VOL. 10(3).
  17. Charles Hua Chiang Siow, EurNeurol 2008;60:264–266.
  18. KavianGhandehari et al. NeuroAid (MLC601) versus piracetam in the recovery of post-infarct homonymous hemianopsia. Neural Regeneration Research. 2011;6(6):418-422.
 
Safety:
  1. Shahripour RB, et al. Chin J Integr Med 2013.
  2. Young SHY, et al. Cerebrovasc Dis 2010.
  3. Gan R, et al. Cerebrovasc Dis 2008.
 
 
Ongoing Clinical Trials:
  1. Venketasubramanian N, et al. Cerebrovasc Dis 2013
  2. Navarro JC et al. Int J Stroke 2013
  3. Chen C, et al. Cerebrovasc Dis 2013.
  4. RohitBhattacharjee, Auckland University of Technology, New Zealand 2016. (Data on File).
  5. NarayanaswamyVenketasubramanian et al. BMJ Open 2015;5.
Hemorrhagic Stroke and Traumatic Brain Injury:
  1. Yeo TT, et al. Poster WSC Seoul 2010.
  2. Kumar R et al. Cerebrovasc Dis 2015;40(suppl 1):1–76
 
 
Alzheimer's disease:
  1. Pakdaman et al - Effectiveness and Safety of MLC601 in Alzheimer Disease – 2015.
  2. Lim YA, et al. Cerebrovasc Dis 2013.
  3. Harandi AA, et al. Brit Med Med Res 2013.
 
 
Review Papers:
  1. Dib M et al - Review of Clinical Studies - European Journal of Medicinal Plant2015.
  2. Heurteaux C et al - Pharmacology Review - Cerebrovasc Dis 2013;35(suppl 1):1–7.
  3. Fahad Javaid Siddiqui et al. Cerebrovasc Dis 2013;35(suppl 1):8–17.
 
 
חברת לבפארם תשמח לשלוח כל מאמר בשלמותו, לכל דורש. פנו אלינו דרך "שירות לקוחות" שבאתר זה.